From the Editor’s desk Highlights from the STI BMJ journal – Oct 2022

Predicting adherence to antiretroviral therapy among people living with HIV

Investigators in Shenzhen, China have developed a model that accurately estimates ART adherence behaviour. Which five key predictors did they identify?
http://dx.doi.org/10.1136/sextrans-2021-055222

Sexual contact between gonorrhoea treatment and attending for a test of cure

In England, among participants of all ages recruited into the ‘Gentamicin for the Treatment of Gonorrhoea’ trial, 197/540 (37%) reported sexual contact in the time between treatment and ToC. How many also reported inconsistent condom use?
http://dx.doi.org/10.1136/sextrans-2021-055029

Syphilis diagnoses during the COVID-19 pandemic in Brazil

Between March and December 2020, the incident rate of syphilis across all regions of Brazil was 367 (95% CI 364-369) reported cases per million population. How did this compare with pre-pandemic rates?
http://dx.doi.org/10.1136/sextrans-2021-055240

Perspectives

If you missed the previous prompt, here is our selection of unmissable research news, from CoronaVac immunogenicity in people living with HIV to the effects of DTG + TAF/FTC on genital shedding of HIV.
http://dx.doi.org/10.1136/sextrans-2021-055338

BMJ Talk Medicine

Have you had a chance to listen to our recent podcast? We talked to Joel Palefsky about preventing anal cancer in people with HIV and the key learnings from the ANCHOR study.

https://soundcloud.com/bmjpodcasts/sti-anchor-study?in=bmjpodcasts/sets/sti

Find these and more at https://sti.bmj.com/

Enjoy!

Anna Maria Geretti, Editor in Chief

(Visited 32 times, 1 visits today)